BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.120
0.00 (0.00%)
Sep 25, 2026, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 554.52 million as of September 25, 2026. Its market cap has decreased by -4.72% in one year.
Market Cap
554.52M
Enterprise Value
485.91M
Revenue
38.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.12
ChartMarket Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 554.52M, an increase of 636.63%. That is a compound annual growth rate of 9.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 554.52M | 9.81% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 136.96B |
| Coloplast | 94.48B |
| Demant | 65.38B |
| ChemoMetec | 8.88B |
| Gubra | 5.00B |
| Pharma Equity Group | 98.20M |
| ViroGates | 92.82M |